It’s another up-and-down day as investors try to weigh what seems to be a strong U.S. economy and weakening global economy. This of course, makes it tough to bid up stocks to new highs, but at the same time, it’s hard to sell U.S. equities when it’s the best house in the neighb
This article is about Domino’s Pizza (DPZ) and why it's a great buy for the total return investor that also wants some dividend income. Domino’s Pizza is one of the largest fast food companies in the United States and foreign countries.
BMO Capital Markets analyst M. IanSomaiya and team take a look at the “clinical readouts through the end of 2016″ and find upside catalysts for Celgene (CELG), Amgen (AMGN), Biogen (BIIB), and Gilead Sciences (GILD) They explain:
Paulo Fridman/Bloomberg News
Celgene: We believe positive data from the mongersen Phase 2 endoscopy study should move shares higher if....More>>>
As the world shifts from legacy distribution to mobile and over-the-top viewing, both Time Warner (NYSE:TWX) and AT&T (NYSE:T) face a slowing growth long-term outlook, but in different ways. It’s totally understandable that these companies would consider solving their perceived problems and resolving their issues via mergers. Big Phone has a need for content to fill its massive distribution....More>>>
American Express (AXP) is stuck between a rock and a hard place. As it battles MasterCard (MA) and Visa (V), American Express can either try to match their rewards–which will damage its returns–or stand its ground, which will make it hard to compete. Evercore ISI’s David Togut and team explain:
Credit card rewards continue to spiral skywards asAmerican....More>>>
Leerink’s Geoffrey Porges and Assaf Vestin are attending the annual American Society of Clinical Oncology, or ASCO, meeting and came away seeing the “biggest positive impact” forCelgene (CELG), but only a “modest” impact for Amgen (AMGN),Regeneron Pharmaceuticals (REGN) and Gilead Sciences (GILD). They explain:
Data on initial jobless claims for the latest week will be released at 8:30 a.m. ET. The Chicago PMI for June is scheduled for release at 9:45 a.m. ET. The Energy Information Administration’s weekly report on natural gas stocks will be released at 10:30 a.m. ET. St. Louis Federal Reserve Bank President James Bullard is set to speak in London at 2:00 p.m. ET. ....More>>>
Related ALJ Barclays Ratings And Price Target Changes For Wednesday, July 13, 2016 Delek Holdings Downgraded At JPMorgan, Price Target Cut Following Sum Of The Parts Valuation The Refining Industry's Summer Of Discontent (Seeking Alpha) Related DK Barclays Ratings And Price Target Changes For Wednesday, July....More>>>
JPMorgan’s Jamie Baker and Nishant Mani argue that “downside risk appears diminutive” in airlines like Delta Air Lines (DAL), Southwest Airlines (LUV), and American Airlines (AAL)–even if there’s a recession. They explain why:
Were over a year into fuels decline, and investor fears concerning a breakdown in discipline havent materialized.....More>>>
Regeneron Pharmaceuticals (REGN) lost a patent case with Amgen (AMGN) and now a judge will have to make a decision regarding an injunction on sales of Praluent. Citigroup’s Robyn Karnauskas and Mohit Bansal provide and update:
We spoke to Regeneron regarding the timelines of the injunction decision in the PCSK9 patent case and the company noted that the Judges opinion could come in....More>>>
The coffee market is back in the news, but the latest development may not have a big impact 0n Starbucks (NASDAQ:SBUX), stock. Burger King recently announced a $5 per month coffee subscription model, giving members one free cup of coffee per day.
On Thursday, shares of Biogen (NASDAQ:BIIB) were hammered, falling more than 29% in just one session. Biogen stock was again under pressure on Friday, falling almost 3% on the day. The move puts the stock down massively on the week and below key support.